Related references
Note: Only part of the references are listed.The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
Cristina Garcia-de-la-Maria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada
George G. Zhanel et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2018)
Elucidation of the pharmacokinetic/ pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model
Hajira Bilal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa
Xuan Yang et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy
Fekade Bruck Sime et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Fosfomycin: Pharmacological, Clinical and Future Perspectives
Anneke Corinne Dijkmans et al.
ANTIBIOTICS-BASEL (2017)
Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers
E. Wenzler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Intravenous fosfomycin-back to the future. Systematic review and meta-analysis of the clinical literature
B. Grabein et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model
Brian VanScoy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model
Ashley D. Hall Snyder et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Pharmacokinetics and total removal of fosfomycin in two patients undergoing intermittent haemodialysis and extended dialysis: prescription needs to avoid under-dosing
Julius J. Schmidt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model
Brian D. VanScoy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
F. Docobo-Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Population Pharmacokinetics of Fosfomycin in Critically Ill Patients
Suzanne L. Parker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments
Mahableshwar S. Albur et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Fosfomycin versu meropenem in bacteraemic urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
Clara Rosso-Fernandez et al.
BMJ OPEN (2015)
Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
Konstantinos Pontikis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Combination therapy for carbapenem-resistant Gram-negative bacteria
Alexandre P. Zavascki et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
Alfredo Castaneda-Garcia et al.
ANTIBIOTICS-BASEL (2013)
'Old' antibiotics for emerging multidrug-resistant bacteria
Phillip J. Bergen et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin
Anucha Apisarnthanarak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Fosfomycin: Efficacy against infections caused by multidrug-resistant bacteria
Aurelien Dinh et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
A Reappraisal of Current Dosing Strategies for Intravenous Fosfomycin in Children and Neonates
Friederike Traunmueller et al.
CLINICAL PHARMACOKINETICS (2011)
Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
Johan W. Mouton et al.
DRUG RESISTANCE UPDATES (2011)
Adverse events associated with intravenous fosfomycin
Amelie Florent et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
The revival of fosfomycin
Argyris S. Michalopoulos et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Use of High-Dose 4-Hour Infusion of Doripenem, in Combination with Fosfomycin, for Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Pneumonia
Anucha Apisarnthanarak et al.
CLINICAL INFECTIOUS DISEASES (2010)
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
A. Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Extracellular concentrations of fosfomycin in lung tissue of septic patients
Veronika Matzi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Role of Old Antibiotics in Multidrug Resistant Bacterial Infections
R. Maviglia et al.
CURRENT DRUG TARGETS (2009)
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
Nikos Roussos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection
Michael V. Schintler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2008)
Fosfomycin: Use beyond urinary tract and gastrointestinal infections
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE
Louis B. Rice
JOURNAL OF INFECTIOUS DISEASES (2008)
Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration
Rainer Gattringer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Antibiotic abscess penetration: Fosfomycin levels measured in pus and simulated concentration-time profiles
R Sauermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Determination of fosfomycin in pus by capillary zone electrophoresis
M Petsch et al.
JOURNAL OF CHROMATOGRAPHY A (2005)
Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis
B Pfausler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Target site penetration of fosfomycin in critically ill patients
C Joukhadar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome
FJ Legat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro activity of fosfomycin in combination with various antistaphylococcal substances
K Grif et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues
M Frossard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
